| Name | Title | Contact Details |
|---|
BHG is transforming the financial industry; leveraging the power of data, analytics, and cutting-edge technology to become not only the number one source for professional loans, but also the creator of the largest community bank loan and product network in the country. Since 2001, BHG has originated more than $8 billion in loan solutions to top-quality borrowers, which community and midsize banks can access via a state-of-the-art loan delivery platform. Building on nearly two decades of innovation, BHG and its family of brands now offer a full suite of financial solutions that span business, consumer, and SBA 7(a) loans, credit cards, collection services, risk management services, and point-of-sale financing with a focus in patient lending. With record growth year after year, BHG continues to be recognized regionally and nationally: earning a spot on the Inc. 5000 for 14 years running, and receiving accolades from Great Place to Work® and Fortune magazine, among others. BHG is partially owned by Pinnacle Bank (PNFP) and has headquarters in Davie, FL and Syracuse, NY.
City of Gahanna, located in central ohio, offers family events, great parks and communities, plus the activities and businesses found at Creekside. Learn more about business development, emergency services, legislation, mayor’s court, city council, zon...
Intellivisit Solutions is a healthcare technology and modern urgent care consulting company. Our technology, Intellivisit, is a real-time artificial intelligence decision support tool specifically designed by our experts to enhance urgent care teams. Our consulting, UCP Merchant Medicine, is a full-service, turn-key consulting firm focused on improving strategic, financial, and operational outcomes with our modern urgent care model.
BPR Health International is a Moraga, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cellenkos is an early stage clinical biotechnology company that focuses on cord blood-derived T-regulatory cellular therapies for the treatment of autoimmune diseases and inflammatory conditions. Cellenkos is founded on the technologies arising from the laboratory investigations of Simrit Parmar, M.D. Cellenkos` lead product CK0801 delivers clinically meaningful doses of allogeneic cord blood T-regulatory cells to overcome immune dysfunction.